Coronary Artery Disease
Conditions
Keywords
ONO-1101, Landiolol Hydrochloride, Multi-slice CT, Coronary Artery Disease
Brief summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.
Interventions
DRUGONO-1101
Sponsors
Ono Pharmaceutical Co. Ltd
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 74 Years
Healthy volunteers
No
Inclusion criteria
1. 20-74 years old 2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room
Exclusion criteria
1. Previous allergic reactions to contrast agent 2. Renal failure 3. Asthma 4. Other
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety | — |
| heart rate | — |
| image quality | — |
Countries
Japan
Outcome results
None listed